ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma

Chen, Wanjun; Liang, Weijie; He, Yongjian; Liu, Chixiang; Chen, Hongtian; Lv, Piao; Yao, Yuan; Zhou, Huayou*南方医科大学
MEDICAL ONCOLOGY2022-4DOI: 10.1007/s12032-021-01642-3
5被引18阅读
引用收藏
分享

摘要

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma (NHL). The R-CHOP immunochemotherapy regimen is the first-line treatment option for DLBCL patients and has greatly improved the prognosis of DLBCL, making it a curable disease. However, drug resistance or relapse is the main challenge for current DLBCL treatment. Studies have shown that the tumor microenvironment plays an important role in the onset, development, and responsiveness to drugs in DLBCL. Here, we used the CIBERSORT algorithm to resolve the composition of the immune microenvironment of 471 DLBCL patients from the GEO database. We found that activated memory CD4+ T cells and gamma delta T cells were significantly associated with immunochemotherapy response. Weighted gene co-expression networks (WGCNA) were constructed using differentially expressed genes from immunochemotherapy responders and non-responders. The module most associated with these two types of T cells was defined as hub module. Enrichment analysis of the hub module showed that baseline immune status was significantly stronger in responders than in non-responders. A protein-protein interaction (PPI) network was constructed for hub module to identify hub genes. After survival analysis, five prognosis-related genes (CD3G, CD3D, GNB4, FCHO2, GPR183) were identified and all these genes were significantly negatively associated with PD1. Using our own patient cohort, we validated the efficacy of CD3G and CD3D in predicting immunochemotherapy response. Our study showed that CD3G, CD3D, GNB4, FCHO2, and GPR183 are involved in the regulation of the immune microenvironment of DLBCL. They can be used as biomarkers for predicting immunochemotherapy response and potential therapeutic targets in DLBCL.

学科与关键词

关键词
Diffuse large B-cell lymphomaImmune microenvironmentBioinformaticsImmunochemotherapy responsePrognosis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
MEDICAL ONCOLOGY
发表日期
2022-04
卷期
第 39 卷, 第 4 期
页码
44
DOI
10.1007/s12032-021-01642-3
语言
ENGLISH
期刊等级
4区
成果收录
SCIE

作者

  • C

    Chen, Wanjun (第一作者)

    southern med univ

  • L

    Liang, Weijie

    southern med univ

查看全部 8 位作者收起作者
  • H

    He, Yongjian

    southern med univ

  • L

    Liu, Chixiang

    southern med univ

  • C

    Chen, Hongtian

    southern med univ

  • L

    Lv, Piao

    southern med univ

  • Y

    Yao, Yuan

    southern med univ

  • Z

    Zhou, Huayou (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417